DiscoverHealio RheuminationsNSAIDs, Part 2: The Dawn of the Anti-Inflammatories
NSAIDs, Part 2: The Dawn of the Anti-Inflammatories

NSAIDs, Part 2: The Dawn of the Anti-Inflammatories

Update: 2024-06-26
Share

Description

In this episode, we dive into the story of aspirin and the development of ibuprofen, ending with the experiments that showed the mechanism of how aspirin actually works.

  • Intro 0:12
  • Review of part 1 0:28
  • In this episode 1:04
  • Blocking prostaglandins and willow leaves 2:26
  • Edward Stone 3:45
  • Johann Andreas Buchner 4:16
  • The chemical structure of salicylic acid and creating the synthetic compound 4:44
  • Dr. TJ MacLagan: The first trial in 1876 and treating acute rheumatism 5:16
  • Felix Hoffmann: manipulating salicylic acid and aspirin 8:47
  • How widespread was the use of aspirin for rheumatoid arthritis? 12:04
  • 1938: problems with aspirin and endoscopies 14:58
  • 1950s: long-term use of aspirin and chronic renal impairment 17:12
  • Dr. Lawrence Craven: the use of aspirin to treat myocardial infarction 18:13
  • Overview of what we’ve learned so far 20:48
  • Stewart Adams: the development of ibuprofen 21:40
  • A paper lost to time 23:29
  • How do you test if a drug is anti-inflammatory? 25:25
  • How do you make better aspirin? 26:55
  • 1960: a trial comparing ibuprofen, baby aspirin and prednisone in patients with rheumatoid arthritis 30:03
  • Aspirin, ibuprofen and other NSAIDs 32:49
  • Nobel Prize winner Dr. John Vane 33:40
  • Dr. Vane: what triggered prostaglandin production? 35:42
  • Another guinea pig experiment 37:37
  • Nobel Prize winner Dr. Bengt Samuelsson 39:00
  • Interesting tidbits: early studies looking at the side effects of NSAIDs 40:01
  • 1968: gastric ulcer formation and prostaglandins in rats 40:25
  • 1973: renal blood flow and prostaglandins in dogs 41:53
  • 1974: aspirin vs ibuprofen vs indomethacin for the heart 44:03
  • Aspirin vs ibuprofen vs indomethacin 44:20
  • On the next episode 46:09
  • Thanks for listening 46:37

We’d love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum.

References:

Adams SS. Inflammopharmacology. 1999;doi:10.1007/s10787-999-0002-3.

https://www.aspirin-foundation.com/history/the-aspirin-story/.

Buchanan WW, et al. J Rheumatol. 2002;29(6):1321-3.

Cryer B, et al. Gastroenterology. 1999;doi:10.1016/s0016-5085(99)70545-7.

Desborough MJR, et al. Br J Haematol. 2017;doi:10.1111/bjh.14520.

Halford GM, et al. Platelets. 2012;doi:10.3109/09537104.2011.632032.

Harris SC, Fosdick LS. Theoretical considerations of the mechanisms of antipyretic analgesia. NWU Bull. 1952;53: 6–9.

Jasani MK, et al. Ann Rheum Dis. 1968;doi:10.1136/ard.27.5.457.

Robert A, et al. Gastroenterology. 1968;55(4):481-7.

Disclosures: Brown reports no relevant financial disclosures.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

NSAIDs, Part 2: The Dawn of the Anti-Inflammatories

NSAIDs, Part 2: The Dawn of the Anti-Inflammatories

Healio